GSA Capital Partners’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,936
| Closed | -$250K | – | 1943 |
|
|
2024
Q4 | $250K | Buy |
+10,936
| New | +$250K | 0.02% | 1313 |
|
|
2022
Q2 | – | Sell |
-6,394
| Closed | -$240K | – | 1671 |
|
|
2022
Q1 | $240K | Sell |
6,394
-151
| -2% | -$5.67K | 0.03% | 1052 |
|
|
2021
Q4 | $631K | Buy |
6,545
+2,774
| +74% | +$267K | 0.08% | 451 |
|
|
2021
Q3 | $545K | Buy |
+3,771
| New | +$545K | 0.06% | 649 |
|
|
2019
Q1 | – | Sell |
-3,711
| Closed | -$160K | – | 1597 |
|
|
2018
Q4 | $160K | Sell |
3,711
-5,611
| -60% | -$242K | 0.02% | 1151 |
|
|
2018
Q3 | $546K | Buy |
+9,322
| New | +$546K | 0.03% | 1029 |
|
|
2018
Q2 | – | Sell |
-1,215
| Closed | -$342K | – | 1851 |
|
|
2018
Q1 | $342K | Buy |
+1,215
| New | +$342K | 0.02% | 1261 |
|